Alzheimer’s Risk May Begin Before 30, New Study Warns

Genetic mutations predict Alzheimer’s onset like a ticking clock, study finds

New research published in Molecular Neurodegeneration has revealed that mutations in three genes known to cause familial Alzheimer’s disease can predict when symptoms will begin. By analyzing how these mutations alter the production of amyloid-beta peptides in the brain, scientists found that each mutation acts like a molecular clock—shifting the age at which individuals develop dementia. These findings provide a deeper understanding of the dise…

Alzheimer’s Risk May Begin Before 30, New Study Warns

Cognitive function was found to be associated with established risk factors and biomarkers as early as age 24. A new study led by researchers at Columbia University’s Mailman School of Public Health and the Columbia Butler Aging Center reveals that risk factors and biological markers linked to Alzheimer’s disease may influence cognitive function much earlier [...]

New study suggests Alzheimer’s may be reversible

Researchers may have found a way to reverse Alzheimer's in some early-stage patients, but more research is needed to prove it.

Older people with this trait may be lowering their risk of dementia: study

More than 6 million Americans have dementia, which affects memory, language and problem-solving skills. Several lifestyle factors can lower dementia risk, including one revealed in a new study.

HIV drugs offer substantial Alzheimer’s protection, study finds

Alzheimer’s disease stands as the most widespread form of dementia globally, increasingly burdening families, healthcare systems, and societies as populations age. Although current treatments, including acetylcholinesterase and amyloid-beta (Aβ) inhibitors, offer some relief, they don’t effectively halt disease progression. Now, researchers from UVA Health have uncovered a promising link between drugs initially developed for HIV and reduced Alzh…

ISMRM: Diffusion MRI predicts progression to Alzheimer's

A presentation at ISMRM 2025 suggests diffusion MRI could predict progression from mild cognitive impairment to Alzheimer's.